• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微创伤引起的反复前房积血及与长期使用乙酰水杨酸相关的继发性青光眼。

Microtrauma-induced recurrent hyphema and secondary glaucoma associated with chronic acetylsalicylic acid use.

作者信息

Elgin Ufuk, Sen Emine, Teke Mehmet Y, Tirhis Hakan, Ozturk Faruk

机构信息

Department of Ophthalmology, Ulucanlar Eye Research Hospital, 24 Sokak, 13/4 06490, Bahcelievler, Ankara, Turkey.

出版信息

Int Ophthalmol. 2012 Feb;32(1):89-92. doi: 10.1007/s10792-012-9517-5. Epub 2012 Feb 2.

DOI:10.1007/s10792-012-9517-5
PMID:22298034
Abstract

To report a case of microtrauma-induced recurrent hyphema and secondary glaucoma associated with voluntary chronic acetylsalicylic acid (ASA) use. A 43-year-old male developed advanced glaucoma in his right eye after a two-month followup period of recurrent microhyphema, which had been induced by strong eye-rubbing. In spite of topical and systemic antiglaucoma medication, as well as topical corticosteroid and cycloplegic drugs and bed rest under hospitalization, the hyphema and glaucoma were not controlled. His medical history revealed that he had been using ASA for 2 years in order to prevent heart attacks. We asked the patient to stop ASA intake and the hyphema cleared considerably on the third day after discontinuation of the drug. One week after stopping ASA, trabeculectomy with mitomycin C was performed without any complications. Glaucoma and recurrent hyphema were controlled after surgery without any medical treatment. Chronic ASA intake may cause recurrent hyphema and secondary glaucoma even after a microtrauma. Medical histories of patients must always be taken, especially in cases of prolonged recurrent hyphema.

摘要

报告一例因微小创伤诱发的反复前房积血及继发性青光眼病例,该病例与长期自愿服用乙酰水杨酸(ASA)有关。一名43岁男性在经历了两个月因用力揉眼诱发的反复微小前房积血的随访期后,右眼发展为晚期青光眼。尽管使用了局部及全身抗青光眼药物,以及局部皮质类固醇、睫状肌麻痹药物并住院卧床休息,前房积血和青光眼仍未得到控制。其病史显示,他为预防心脏病发作已服用ASA两年。我们要求患者停止服用ASA,停药后第三天前房积血明显消退。停用ASA一周后,进行了丝裂霉素C辅助的小梁切除术,未出现任何并发症。术后无需任何药物治疗,青光眼和反复前房积血即得到控制。长期服用ASA即使在微小创伤后也可能导致反复前房积血和继发性青光眼。必须始终询问患者的病史,尤其是在长期反复前房积血的病例中。

相似文献

1
Microtrauma-induced recurrent hyphema and secondary glaucoma associated with chronic acetylsalicylic acid use.微创伤引起的反复前房积血及与长期使用乙酰水杨酸相关的继发性青光眼。
Int Ophthalmol. 2012 Feb;32(1):89-92. doi: 10.1007/s10792-012-9517-5. Epub 2012 Feb 2.
2
Angle-recession glaucoma: long-term clinical outcomes over a 10-year period in traumatic microhyphema.房角后退性青光眼:外伤性微小前房积血10年的长期临床转归
Int Ophthalmol. 2015 Feb;35(1):107-13. doi: 10.1007/s10792-014-0027-5. Epub 2014 Dec 18.
3
Trabeculectomy for traumatic hyphema in sickle cell trait.镰状细胞性状外伤性前房积血的小梁切除术
Semin Ophthalmol. 2015 Jul;30(4):297-304. doi: 10.3109/08820538.2013.847108. Epub 2013 Nov 19.
4
[Traumatic hyphema caused by eye injuries].[眼外伤所致外伤性前房积血]
Klin Oczna. 2005;107(4-6):250-1.
5
Evaluation of recurrent hyphema after trabeculectomy with ultrabiomicroscopy 50-80 MHz: a case report.使用50 - 80兆赫超生物显微镜评估小梁切除术后复发性前房积血:一例报告
BMC Res Notes. 2012 Oct 4;5:549. doi: 10.1186/1756-0500-5-549.
6
Traumatic hyphema in a patient with severe hemophilia A: Clinical features and management.血友病 A 患者创伤性前房积血:临床特征与处理。
Eur J Ophthalmol. 2021 Mar;31(2):NP106-NP108. doi: 10.1177/1120672119856515. Epub 2019 Jun 12.
7
Uveitis-glaucoma-hyphema syndrome and corneal decompensation in association with cosmetic iris implants.葡萄膜炎-青光眼-前房积血综合征与角膜失代偿合并美容性虹膜植入物
Am J Ophthalmol. 2009 Nov;148(5):790-3. doi: 10.1016/j.ajo.2009.06.008. Epub 2009 Aug 5.
8
Trabeculectomy for traumatic hyphema with increased intraocular pressure.
Am J Ophthalmol. 1994 Feb 15;117(2):155-9. doi: 10.1016/s0002-9394(14)73070-3.
9
Medical interventions for traumatic hyphema.外伤性前房积血的医学干预措施。
Cochrane Database Syst Rev. 2011 Jan 19(1):CD005431. doi: 10.1002/14651858.CD005431.pub2.
10
Recurrent traumatic hyphema. A sequel of injury to the Schlemm canal.复发性外伤性前房积血。施莱姆管损伤的后遗症。
Arch Ophthalmol. 1977 Mar;95(3):484-5. doi: 10.1001/archopht.1977.04450030126019.

引用本文的文献

1
Delayed Obstruction of XEN Gel Stent by Cell Debris in Primary Open-angle Glaucoma: A New Insight into the Pathophysiology of Filtration Device Failure.原发性开角型青光眼中细胞碎片导致XEN凝胶支架延迟阻塞:对滤过装置失败病理生理学的新见解。
J Curr Glaucoma Pract. 2019 Sep-Dec;13(3):113-115. doi: 10.5005/jp-journals-10078-1258.

本文引用的文献

1
Low-dose aspirin therapy for cardiovascular prevention: quantification and consequences of poor compliance or discontinuation.低剂量阿司匹林用于心血管预防:不遵医嘱或停药的量化评估及后果。
Am J Cardiovasc Drugs. 2010;10(2):125-41. doi: 10.2165/11318440-000000000-00000.
2
Bleeding in patients using new anticoagulants or antiplatelet agents: risk factors and management.使用新型抗凝剂或抗血小板药物患者的出血:危险因素与管理
Neth J Med. 2010 Feb;68(2):68-76.
3
Incidence and risk factors in secondary glaucomas after blunt and penetrating ocular trauma.
钝性和穿透性眼外伤后继发性青光眼的发病率及危险因素
J Glaucoma. 2007 Dec;16(8):685-90. doi: 10.1097/IJG.0b013e318073bd4d.
4
The effect of aspirin and warfarin therapy in trabeculectomy.阿司匹林和华法林治疗在小梁切除术中的作用。
Eye (Lond). 2007 May;21(5):598-603. doi: 10.1038/sj.eye.6702277. Epub 2006 Mar 3.
5
Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery.
Ophthalmology. 2003 Sep;110(9):1784-8. doi: 10.1016/S0161-6420(03)00785-1.
6
Management of traumatic hyphema.外伤性前房积血的处理
Surv Ophthalmol. 2002 Jul-Aug;47(4):297-334. doi: 10.1016/s0039-6257(02)00317-x.
7
Traumatic glaucoma.
J Glaucoma. 2001 Oct;10(5):436-9. doi: 10.1097/00061198-200110000-00014.
8
Aspirin and warfarin therapy in oculoplastic surgery.眼部整形手术中的阿司匹林和华法林治疗
Br J Ophthalmol. 2000 Dec;84(12):1426-7. doi: 10.1136/bjo.84.12.1426.
9
Aspirin and recurrent hyphema after blunt ocular trauma.阿司匹林与钝性眼外伤后的复发性前房积血
Am J Ophthalmol. 1984 May;97(5):663-4. doi: 10.1016/0002-9394(84)90403-3.
10
Aspirin and secondary bleeding after traumatic hyphema.阿司匹林与外伤性前房积血后的继发性出血
Ann Ophthalmol. 1988 Apr;20(4):157-8.